TY  - JOUR 
AU  - García Sanz, Ramón
AU  - González Porras, José Ramón
AU  - Hernández, J. M.
AU  - Polo-Zarzuela, M
AU  - Sureda, Anna
AU  - Barrenetxea, C
AU  - Palomera, Luis
AU  - López, R
AU  - Grande-García, C
AU  - Alegre, Adrian
AU  - Vargas-Pabón, M
AU  - Gutiérrez, O N
AU  - Rodríguez, J A
AU  - San Miguel Izquierdo, Jesús Fernando
PY  - 2004
SN  - 0887-6924
UR  - http://hdl.handle.net/10366/155215
AB  - [EN]We evaluate the efficacy of the oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) in 71 refractory/relapsed multiple myeloma patients, including a prognostic analysis to predict both response and survival. Patients...
LA  - eng
PB  - Springer Nature
KW  - Myeloma
KW  - Thalidomide
KW  - Cyclophosphamide
KW  - Dexamethasone
KW  - beta 2-Microglobulin
KW  - Aged
KW  - Cyclophosphamide
KW  - Humans
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Middle Aged
KW  - Prognosis
KW  - Multiple Myeloma
KW  - Salvage Therapy
KW  - Thalidomide
KW  - Treatment Outcome
KW  - Remission Induction
KW  - Survival Analysis
KW  - Dexamethasone
TI  - The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma
DO  - 10.1038/sj.leu.2403322
T2  - Leukemia
VL  - 18
M2  - 856
ER  -